Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00600964 · ClinicalTrials.gov registry record · Phase 1
A Phase I/II Study of GX15-070MS in Untreated CLL
A Phase 1 study, sponsored by Gemin X.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT00600964: Completed Phase 1 study, sponsored by Gemin X.
NCT00600964 is a Phase 1 study that has completed, run by Gemin X. The registered enrollment target is 26 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00600964, a Phase 1 study, has completed, sponsored by Gemin X.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
This protocol is being run to determine the best phase II dose and schedule of obatoclax in patients with previously untreated CLL.
Interventions
- DRUG GX15-070MS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2004-09 |
| Est. Completion | 2006-01 |
| Phase | Phase 1 |
What the finished NCT00600964 record still lists
NCT00600964 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 1 intervention - of which GX15-070MS is the first listed.
NCT00600964 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00600964 about?
NCT00600964 is a clinical study titled "A Phase I/II Study of GX15-070MS in Untreated CLL". This protocol is being run to determine the best phase II dose and schedule of obatoclax in patients with previously untreated CLL.
What is the current status of trial NCT00600964?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2004-09. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00600964?
The interventions under investigation include: GX15-070MS (DRUG).
Who is sponsoring clinical trial NCT00600964?
This trial is sponsored by Gemin X, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00600964's enrollment target sits among peer trials
26 1482nd of 2000 higher than 506 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia